MFDS — authorised 13 August 1962
- Marketing authorisation holder: KING PHARMS
- Status: likely_approved
🇰🇷 Skelaxin in South Korea
MFDS authorised Skelaxin on 13 August 1962
Marketing authorisation
Skelaxin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in South Korea
Frequently asked questions
Is Skelaxin approved in South Korea?
Yes. MFDS authorised it on 13 August 1962.
Who is the marketing authorisation holder for Skelaxin in South Korea?
KING PHARMS holds the South Korean marketing authorisation.